25 Feb. 2026 /Mpelembe Media/ — A leaked draft of a $1bn health financing agreement between the US and Zambia has provoked widespread backlash and accusations of “shameless exploitation”. Under the proposed memorandum of understanding, Washington would provide health funding in exchange for severe and unprecedented conditions that advocates argue are vastly worse than deals struck with other African nations. Continue reading
23 Feb. 2026 /Mpelembe Media — Researchers have identified a burgeoning psychological crisis labeled AI replacement dysfunction (AIRD), which stems from the pervasive fear of professional obsolescence. This condition manifests as a specific cluster of symptoms including insomnia, paranoia, and a loss of identity triggered by the constant threat of automated labor. While not yet an official medical diagnosis, experts argue that the existential anxiety caused by industry leaders predicting massive job losses constitutes an “invisible disaster.” Evidence suggests that high-profile layoffs at major tech firms are already validating these fears and negatively impacting employee mental health. To address this, the authors advocate for specialized clinical screening to distinguish technology-related distress from traditional psychiatric disorders. Ultimately, the source emphasizes that the societal shift toward AI requires new community and medical frameworks to support a vulnerable workforce. Continue reading
Feb 19, 2026 /Mpelembe media/ — CuraFlow AI is an advanced healthcare orchestration platform designed to assist clinical professionals through multi-agent AI workflows. Powered by the Google Gemini API, the system automates a sequential clinical process involving specialized agents. Continue reading
01, Feb. 2026 /Mpelembe Media/ — Swiss brand Paremina is redefining longevity by blending geroscience with luxury. Its Ageless Cell supplement uses the Epicell™ formula to target biological aging and protect telomeres. This evidence-based approach reflects a global shift toward healthspan as a status symbol. Based on particularly the philosophy of Swiss longevity pioneer Paremina, the transition from aging to an ageless lifestyle is defined by the following key principles: Continue reading
Jan. 29, 2026 /Mpelembe Media/ — Since late December 2025, devastating floods triggered by heavy rains have ravaged the Lundazi and Lumezi districts in Zambia’s Eastern Province. The disaster submerged dams, swept away homes, and destroyed critical infrastructure, leaving more than 40,000 people without access to safe drinking water after the main treatment plant was compromised. This has created a severe health crisis for children, who face heightened risks of cholera, diarrhea, and malaria, while also suffering from extreme food insecurity due to the destruction of stored maize and agricultural livelihoods. Continue reading
Alveo Technologies and Global Animal Health have entered into a strategic collaboration to implement a large-scale avian influenza monitoring program throughout Egypt. This initiative utilizes the Alveo Sense platform, a portable diagnostic tool that provides molecular-grade results on-site in under an hour. By moving away from slow, centralised laboratory testing, the partnership aims to help farmers and veterinarians identify outbreaks early and protect national food security. The system also features digital data integration, allowing authorities to track the spread of the virus across the region in real time. This deployment represents the first mass-scale use of this decentralised technology for poultry health, with future plans to expand throughout the Middle East. Continue reading
Dec. 03, 2025 /Mpelembe Media/ — This document announces the publication of a significant real-world evaluation concerning the effectiveness of an artificial intelligence platform used in acute stroke diagnosis. Brainomix, a medical imaging company, reported that its software, Brainomix 360 Stroke, was successfully studied over a five-year period using national data from over 450,000 patients admitted to NHS hospitals in England. The study found that using the AI platform was associated with a remarkable 100% increase in endovascular thrombectomy rates, which is a crucial procedure for treating severe strokes. Experts involved in the NHS collaboration affirmed that the technology significantly reduced delays in patient transfer and diagnosis, helping to increase treatment accessibility, especially in primary stroke centres lacking immediate specialist resources. Ultimately, the data supports the general use of AI imaging decision-support software in clinical guidelines due to its ability to improve patient outcomes. Continue reading
The core information from DataM Intelligence indicates that the market was valued at USD 13.22 billion in 2024 and is projected to double to USD 28.10 billion by 2033 due to advancements in precision medicine, hormonal therapies, and targeted radioligands. Segmentation analysis breaks down the market by therapy type, dominated by hormonal therapy (57% share), as well as by administration route (mostly oral) and distribution channel (led by hospital pharmacies). Furthermore, the report highlights key growth drivers like rising global incidence and provides competitive analysis, naming major players such as Novartis AG and Johnson & Johnson, and discusses regional revenue leadership by the United States. Continue reading →
Nov. 23, 2025 /Mpelembe Media/ — A market insights report on the Alcohol Use Disorder (AUD) treatment market conducted by a life sciences market research firm, forecasts that the AUD market will grow rapidly at a Compound Annual Growth Rate (CAGR) of 13.6% by 2034, driven by rising disease prevalence and advancements in innovative therapies, including genetically-targeted treatments. The AUD market size was estimated at USD 1.1 billion in 2024 across seven key markets, with the United States accounting for the majority of the revenue. The report discusses current treatments and several emerging therapies in the pipeline from companies like Adial Pharmaceuticals and Beckley Psytech, which are expected to reshape the treatment landscape despite an ongoing significant treatment gap in patient care. Continue reading